Chengming H. Qu
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Therapeutic targeting of AREL1 in hepatic stellate cells attenuates MASH-related liver fibrosis.
Journal: Nature communications
Published: November 27, 2025
Engineered CAR-NKT Extracellular Vesicles Suppress Tumor Progression and Enhance Antitumor Immunity.
Engineered CAR-NKT Extracellular Vesicles Suppress Tumor Progression and Enhance Antitumor Immunity.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 28, 2025
Targeted extracellular vesicle-photoimmunotherapy remodels stromal-immune microenvironment to boost chemo-immunotherapy in preclinical models.
Journal: Cell reports. Medicine
Published: June 04, 2025
Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma.
Journal: Cell death & disease
Published: November 16, 2024
WDR4 drives tumour-associated macrophage reprogramming and tumour progression via selective translation and membrane cholesterol efflux.
Journal: Nature cell biology
Published: November 14, 2024
Nanobody Engineered and Photosensitiser Loaded Bacterial Outer Membrane Vesicles Potentiate Antitumour Immunity and Immunotherapy.
Journal: Journal of extracellular vesicles
Published: October 10, 2024
Targeted degradation of endogenous YAP by nanobody bioPROTAC inhibits tumor progression.
Journal: Nature communications
Published: March 28, 2024
Liver Extracellular Vesicles and Particles Enriched β-Sitosterol Effectively Promote Liver Regeneration in Mice.
Journal: International journal of nanomedicine
Published: February 22, 2024
Nanobody-Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING-Mediated Anti-Tumor Immunity.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 22, 2024
Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the Immunotherapy.
Journal: ACS nano
Published: January 22, 2024
Transcriptomic and metabolomic analysis of peri-tumoral hepatic tissue in hepatocellular carcinoma: unveiling the molecular landscape of immune checkpoint therapy resistance.
Journal: Frontiers in pharmacology
Published: September 30, 2023
A Radiomics Model Based on Gd-EOB-DTPA-Enhanced MRI for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma ≤ 5 cm.
Journal: Frontiers in oncology
Published: December 08, 2021
Last Updated: 09/26/2026